GOODYEAR TIRE & RUBBER CO /OH/ (GT): M&A transaction — Goodyear completes chemical business sale for $650M; Q3 net loss $2.2B on $4.6B revenue

GOODYEAR TIRE & RUBBER CO /OH/

Net loss $2.2B ($7.62/share) includes $1.4B deferred tax valuation allowance and $674M goodwill impairment.
Adjusted net income $82M ($0.28 EPS) vs $102M ($0.36) a year ago; segment operating income $287M down from $346M.
Goodyear Forward delivered $185M segment operating income benefit in Q3; expects ~$1.5B annualized run-rate by year-end 2025.
Chemical business sale closed Oct 31 for $650M; cash proceeds $580M after working capital adjustments.
Total divestiture proceeds ~$2.2B used for debt reduction; all planned asset sales now completed.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

GOODYEAR TIRE & RUBBER CO /OH/ completed a disposition involving G-3 Chickadee Purchaser, LLC for $650 million (closed 2025-10-31).

Action: disposition
Counterparty: G-3 Chickadee Purchaser, LLC
Consideration: $650 million
Closing: 2025-10-31

Exact text from the filing

On October 31, 2025, The Goodyear Tire & Rubber Company, an Ohio corporation (the “ Company ”), completed the previously announced sale of its polymer chemical business (the “ Business ”) to G-3 Chickadee Purchaser, LLC, a Delaware limited liability company (the “ Purchaser ”), for a purchase price of $650 million, subject to adjustments in accordance with the terms of the Asset Purchase Agreement dated as of May 22, 2025 (as amended, the “ Agreement ”), by and between the Company and the Purchaser (the “ Transaction ”).

View on SEC.gov

Browse all m&a transactions →

GOODYEAR TIRE & RUBBER CO /OH/ filing history →

Source: SEC EDGAR

accession 0001628280-25-048294

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.